Cargando…

Activity Changes of the Peptic Lactoferrin Hydrolysate in Human Gastric Cancer AGS Cells in Response to Cu(II) or Mn(II) Addition

Lactoferrin is an interesting bioactive protein in milk and can interact with various metal ions of trace elements such as copper, iron, manganese, and others. In this study, a lactoferrin hydrolysate (LFH) was generated from commercial bovine lactoferrin by protease pepsin, fortified with Cu(2+) (o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bo, Li-Ying, Pan, Zhi-Qin, Zhang, Qiang, Song, Chun-Li, Ren, Jian, Zhao, Xin-Huai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378690/
https://www.ncbi.nlm.nih.gov/pubmed/37509754
http://dx.doi.org/10.3390/foods12142662
_version_ 1785079831147315200
author Bo, Li-Ying
Pan, Zhi-Qin
Zhang, Qiang
Song, Chun-Li
Ren, Jian
Zhao, Xin-Huai
author_facet Bo, Li-Ying
Pan, Zhi-Qin
Zhang, Qiang
Song, Chun-Li
Ren, Jian
Zhao, Xin-Huai
author_sort Bo, Li-Ying
collection PubMed
description Lactoferrin is an interesting bioactive protein in milk and can interact with various metal ions of trace elements such as copper, iron, manganese, and others. In this study, a lactoferrin hydrolysate (LFH) was generated from commercial bovine lactoferrin by protease pepsin, fortified with Cu(2+) (or Mn(2+)) at two levels of 0.64 and 1.28 (or 0.28 and 0.56) mg/g protein, respectively, and then measured for the resultant bioactivity changes in the well-differentiated human gastric cancer AGS cells. The assaying results indicated that the LFH and Cu/Mn-fortified products had long-term anti-proliferation on the cells, while the treated cells showed DNA fragmentation and increased apoptotic cell proportions. Regarding the control cells, the cells treated with the LFH and especially Cu/Mn-fortified LFH had remarkably up-regulated mRNA expression of caspase-3 and Bax by respective 1.21–3.23 and 2.23–2.83 folds, together with down-regulated mRNA expression Bcl-2 by 0.88–0.96 folds. Moreover, Western-blot assaying results also indicated that the cells exposed to the LFH and Cu/Mn-fortified LFH (especially Mn at higher level) for 24 h had an enhanced caspase-3 expression and increased ratio of Bax/Bcl-2. It can thus be concluded that the used Cu/Mn-addition to the LFH may lead to increased bioactivity in the AGS cells; to be more specific, the two metal ions at the used addition levels could endow LFH with a higher ability to cause cell apoptosis by activating caspase-3 and increasing the Bax/Bcl-2 ratio.
format Online
Article
Text
id pubmed-10378690
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103786902023-07-29 Activity Changes of the Peptic Lactoferrin Hydrolysate in Human Gastric Cancer AGS Cells in Response to Cu(II) or Mn(II) Addition Bo, Li-Ying Pan, Zhi-Qin Zhang, Qiang Song, Chun-Li Ren, Jian Zhao, Xin-Huai Foods Article Lactoferrin is an interesting bioactive protein in milk and can interact with various metal ions of trace elements such as copper, iron, manganese, and others. In this study, a lactoferrin hydrolysate (LFH) was generated from commercial bovine lactoferrin by protease pepsin, fortified with Cu(2+) (or Mn(2+)) at two levels of 0.64 and 1.28 (or 0.28 and 0.56) mg/g protein, respectively, and then measured for the resultant bioactivity changes in the well-differentiated human gastric cancer AGS cells. The assaying results indicated that the LFH and Cu/Mn-fortified products had long-term anti-proliferation on the cells, while the treated cells showed DNA fragmentation and increased apoptotic cell proportions. Regarding the control cells, the cells treated with the LFH and especially Cu/Mn-fortified LFH had remarkably up-regulated mRNA expression of caspase-3 and Bax by respective 1.21–3.23 and 2.23–2.83 folds, together with down-regulated mRNA expression Bcl-2 by 0.88–0.96 folds. Moreover, Western-blot assaying results also indicated that the cells exposed to the LFH and Cu/Mn-fortified LFH (especially Mn at higher level) for 24 h had an enhanced caspase-3 expression and increased ratio of Bax/Bcl-2. It can thus be concluded that the used Cu/Mn-addition to the LFH may lead to increased bioactivity in the AGS cells; to be more specific, the two metal ions at the used addition levels could endow LFH with a higher ability to cause cell apoptosis by activating caspase-3 and increasing the Bax/Bcl-2 ratio. MDPI 2023-07-11 /pmc/articles/PMC10378690/ /pubmed/37509754 http://dx.doi.org/10.3390/foods12142662 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bo, Li-Ying
Pan, Zhi-Qin
Zhang, Qiang
Song, Chun-Li
Ren, Jian
Zhao, Xin-Huai
Activity Changes of the Peptic Lactoferrin Hydrolysate in Human Gastric Cancer AGS Cells in Response to Cu(II) or Mn(II) Addition
title Activity Changes of the Peptic Lactoferrin Hydrolysate in Human Gastric Cancer AGS Cells in Response to Cu(II) or Mn(II) Addition
title_full Activity Changes of the Peptic Lactoferrin Hydrolysate in Human Gastric Cancer AGS Cells in Response to Cu(II) or Mn(II) Addition
title_fullStr Activity Changes of the Peptic Lactoferrin Hydrolysate in Human Gastric Cancer AGS Cells in Response to Cu(II) or Mn(II) Addition
title_full_unstemmed Activity Changes of the Peptic Lactoferrin Hydrolysate in Human Gastric Cancer AGS Cells in Response to Cu(II) or Mn(II) Addition
title_short Activity Changes of the Peptic Lactoferrin Hydrolysate in Human Gastric Cancer AGS Cells in Response to Cu(II) or Mn(II) Addition
title_sort activity changes of the peptic lactoferrin hydrolysate in human gastric cancer ags cells in response to cu(ii) or mn(ii) addition
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378690/
https://www.ncbi.nlm.nih.gov/pubmed/37509754
http://dx.doi.org/10.3390/foods12142662
work_keys_str_mv AT boliying activitychangesofthepepticlactoferrinhydrolysateinhumangastriccanceragscellsinresponsetocuiiormniiaddition
AT panzhiqin activitychangesofthepepticlactoferrinhydrolysateinhumangastriccanceragscellsinresponsetocuiiormniiaddition
AT zhangqiang activitychangesofthepepticlactoferrinhydrolysateinhumangastriccanceragscellsinresponsetocuiiormniiaddition
AT songchunli activitychangesofthepepticlactoferrinhydrolysateinhumangastriccanceragscellsinresponsetocuiiormniiaddition
AT renjian activitychangesofthepepticlactoferrinhydrolysateinhumangastriccanceragscellsinresponsetocuiiormniiaddition
AT zhaoxinhuai activitychangesofthepepticlactoferrinhydrolysateinhumangastriccanceragscellsinresponsetocuiiormniiaddition